TBIO Company Profile and Key Details
Telesis Bio, Inc.
TBIO Stock Price Chart
Stock Price Today
Telesis Bio, Inc. (TBIO) stock declined over -28.57%, trading at $0.30 on NASDAQ, down from the previous close of $0.42. The stock opened at $0.33, fluctuating between $0.30 and $0.35 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.
Company Information
| Employees | 137 |
| Beta | 1.76 |
| Sales or Revenue | $27.51M |
| 5Y Sales Change% | 28.208% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Telesis Bio, Inc. (NASDAQ: TBIO) stock price is $0.30 in the last trading session. During the trading session, TBIO stock reached the peak price of $0.35 while $0.30 was the lowest point it dropped to. The percentage change in TBIO stock occurred in the recent session was -28.57% while the dollar amount for the price change in TBIO stock was -$0.12.
The NASDAQ listed TBIO is part of Medical - Devices industry that operates in the broader Healthcare sector. Telesis Bio, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Laurence Warden
Senior Vice President of Engineering & Instrumentation
Richard Lepke
Director of Investor Relations
Mr. Brent M. Hunter
Executive Officer
Mr. Eric Esser
Pres & Chief Operating Officer
Dr. Todd R. Nelson MBA, Ph.D.
Chief Executive Officer & Director
Mr. Daniel G. Gibson Ph.D.
Chief Technology Officer
Mr. Robert H. Cutler
Chief Legal Officer
Ms. Jen Carroll
Vice President of Investor Relations
Ms. Laura B. Puga M.B.A.
Vice President of People & Culture
Mr. Decky Goodrich M.B.A.
Senior Vice President of Commercial Operations
TBIO's closing price is 20% higher than its 52-week low of $0.25 where as its distance from 52-week high of $15.46 is -98.06%.
Number of TBIO employees currently stands at 137.
Official Website of TBIO is: https://codexdna.com
TBIO could be contacted at phone 161 794 57361 and can also be accessed through its website. TBIO operates from 29 Hartwell Ave, Lexington, MASSACHUSETTS 92121-2993, United States.
TBIO stock volume for the day was 7.5K shares. The average number of TBIO shares traded daily for last 3 months was 6.9K.
The market value of TBIO currently stands at $532.75K with its latest stock price at $0.30 and 1.78M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com